troglitazone has been researched along with glucagon in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gumbiner, B; Nolan, JJ; Olefsky, JM; Suter, SL; Wallace, P | 1 |
| Fujiwara, T; Fukami, M; Fukuda, K; Horikoshi, H; Wada, M; Yoshioka, S; Yoshioka, T | 1 |
| Emoto, M; Inoue, Y; Kaku, K; Kaneko, T; Murano, K | 1 |
| Feinglos, MN; Hughes, AT; Luna, B | 1 |
| Gabriely, I; Hawkins, M; Shamoon, H; Wozniak, R | 1 |
| Bollheimer, LC; Buettner, R; Landauer, H; Schölmerich, J; Troll, S; Wrede, CE | 1 |
| Asai, M; Higuchi, S; Hirano, K; Iguchi, K; Kubota, M; Usui, S | 1 |
| Jung, HS; Kim, M; Kim, TK; Kim, TN; Kwon, MJ; Lee, EJ; Lee, SH; Park, JH; Rhee, BD; Shin, HM | 1 |
1 review(s) available for troglitazone and glucagon
| Article | Year |
|---|---|
The use of insulin secretagogues in the treatment of type 2 diabetes.
Topics: Acarbose; Carbamates; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Metformin; Peptide Fragments; Piperidines; Protein Precursors; Risk Factors; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
7 other study(ies) available for troglitazone and glucagon
| Article | Year |
|---|---|
Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects.
Topics: Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromans; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Liver; Male; Middle Aged; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1992 |
Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.
Topics: Administration, Oral; Animals; Blood Glucose; Chromans; Diabetes Mellitus; Glucagon; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Pancreas; Thiazoles; Thiazolidinediones; Troglitazone | 1991 |
CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes.
Topics: Animals; Chromans; Cyclic AMP; Dose-Response Relationship, Drug; Fructosediphosphates; Glucagon; Liver; Male; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Tolbutamide; Troglitazone | 1994 |
Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects.
Topics: Adult; Blood Glucose; Chromans; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Homeostasis; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Norepinephrine; Reference Values; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone | 2001 |
Insulin-sparing effects of troglitazone in rat pancreatic islets.
Topics: Animals; C-Peptide; Chromans; Gene Expression Regulation; Glucagon; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Proglucagon; Proinsulin; Protein Precursors; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones; Troglitazone | 2003 |
Regulators for blood glucose level affect gene expression of aquaporin 3.
Topics: Actins; Androstadienes; Aquaporin 3; Biguanides; Blood Glucose; Blotting, Western; Caco-2 Cells; Chromans; Epinephrine; Gene Expression; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Antagonists; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Thiazolidinediones; Tolbutamide; Troglitazone; Wortmannin | 2006 |
The effect of PPARγ agonist on SGLT2 and glucagon expressions in alpha cells under hyperglycemia.
Topics: Animals; Cells, Cultured; Chromans; Gene Expression Regulation; Glucagon; Glucagon-Secreting Cells; Glucose; Hyperglycemia; Hypoglycemic Agents; Mice; Phosphatidylinositol 3-Kinases; PPAR gamma; Proto-Oncogene Proteins c-akt; Signal Transduction; Sodium-Glucose Transporter 2; Thiazolidinediones; Troglitazone | 2017 |